$BSPK
Bespoke Extracts, Inc. Stock $bspk

$bspk Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023057025 Filed on July 14, 2023

Income Statement

Concept	2023 Q3	2023 Q1	2022 Q1
Revenue	$244.4K	$89.02K	$3.060K
YoY Change		2809.02%	-24.07%
Cost Of Revenue	$146.0K	$78.67K	$850.00
YoY Change	224515.38%	9154.94%	-56.85%
Gross Profit	$98.41K	$10.35K	$2.210K
YoY Change	-151496.92%	368.28%	7.28%
Gross Profit Margin	40.26%	11.63%	72.22%
Selling, General & Admin	$347.7K	$374.5K	$974.9K
YoY Change	-67.49%	-61.58%	219.2%
% of Gross Profit	353.34%	3618.85%	44112.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.180K	$1.785K	$0.00
YoY Change			-100.0%
% of Gross Profit	7.3%	17.25%	0.0%
Operating Expenses	$394.6K	$453.7K	$974.9K
YoY Change	-65.22%	-53.46%	218.35%
Operating Profit	-$296.2K	-$443.4K	-$972.7K
YoY Change	-73.89%	-54.42%	219.78%
Interest Expense	$5.337K
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$5.337K	$2.750K	$180.00
YoY Change	-1293.96%	1427.78%
Pretax Income	-$301.5K	-$440.6K	-$972.5K
YoY Change	-73.41%	-54.69%	219.72%
Income Tax
% Of Pretax Income
Net Earnings	-$301.5K	-$440.6K	-$972.5K
YoY Change	-73.41%	-54.69%	219.72%
Net Earnings / Revenue	-123.37%	-494.99%	-31780.72%
Basic Earnings Per Share	-$0.03	-$0.04	-$0.14
Diluted Earnings Per Share	-$0.01	-$0.04	-$3.091K
COMMON SHARES
Basic Shares Outstanding	10.17M shares	10.11M shares	6.992M shares
Diluted Shares Outstanding	10.17M shares	10.11M shares	6.992M shares

Balance Sheet

Concept	2023 Q3	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$0.00	$94.33K
YoY Change	-100.0%	-100.0%	-81.19%
Cash & Equivalents		$4.365K	$94.33K
Short-Term Investments
Other Short-Term Assets	$25.46K	$80.00K	$11.88K
YoY Change	13.21%	573.4%	-78.72%
Inventory	$25.56K	$13.01K	$46.47K
Prepaid Expenses	$10.70K	$26.36K
Receivables	$45.95K	$46.48K	$23.88K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$96.96K	$148.8K	$176.6K
YoY Change	79.49%	-15.74%	-71.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$42.76K	$48.16K	$334.0K
YoY Change	329.92%	-85.58%	12044.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.00K	$10.00K	$12.00K
YoY Change	-10.58%	-16.67%
Total Long-Term Assets	$291.1K	$329.7K	$346.0K
YoY Change	-7.75%	-4.7%	832.31%
TOTAL ASSETS
Total Short-Term Assets	$96.96K	$148.8K	$176.6K
Total Long-Term Assets	$291.1K	$329.7K	$346.0K
Total Assets	$388.1K	$478.5K	$522.5K
YoY Change	5.0%	-8.43%	-19.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$828.1K	$490.0K	$105.6K
YoY Change	276.67%	363.93%	-11.98%
Accrued Expenses	$64.33K	$60.00K	$61.28K
YoY Change	0.0%	-2.09%
Deferred Revenue
YoY Change
Short-Term Debt	$27.00K	$690.0K	$0.00
YoY Change	-83.13%		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$925.3K	$1.249M	$241.9K
YoY Change	78.22%	416.29%	-60.76%
LONG-TERM LIABILITIES
Long-Term Debt	$849.5K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$167.1K	$200.0K	$264.2K
YoY Change	-27.8%	-24.31%
Total Long-Term Liabilities	$1.017M	$200.0K	$264.2K
YoY Change	339.27%	-24.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$925.3K	$1.249M	$241.9K
Total Long-Term Liabilities	$1.017M	$200.0K	$264.2K
Total Liabilities	$1.942M	$1.449M	$506.1K
YoY Change	158.71%	186.25%	-17.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.10M	-$24.32M
YoY Change	9.66%
Common Stock	$10.17K	$10.17K
YoY Change	-97.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.554M	-$970.3K	$16.43K
YoY Change
Total Liabilities & Shareholders Equity	$388.1K	$478.5K	$522.5K
YoY Change	5.0%	-8.43%	-19.17%

Cashflow Statement

Concept	2023 Q3	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$301.5K	-$440.6K	-$972.5K
YoY Change	-73.41%	-54.69%	219.72%
Depreciation, Depletion And Amortization	$7.180K	$1.785K	$0.00
YoY Change			-100.0%
Cash From Operating Activities	$4.570K	-$207.1K	-$219.8K
YoY Change	-102.62%	-5.79%	-37.94%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		-$13.65K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$20.00K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00		-$33.65K
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.000K	$187.0K	199.5K
YoY Change	-105.63%	-6.28%	-66.74%
NET CHANGE
Cash From Operating Activities	4.570K	-$207.1K	-219.8K
Cash From Investing Activities	0.000		-33.65K
Cash From Financing Activities	-9.000K	$187.0K	199.5K
Net Change In Cash	-4.430K	-$20.07K	-53.90K
YoY Change	-67.71%	-62.77%
FREE CASH FLOW
Cash From Operating Activities	$4.570K	-$207.1K	-$219.8K
Capital Expenditures	$0.00		-$13.65K
Free Cash Flow	$4.570K	-$207.1K	-$206.1K
YoY Change	-102.62%	0.45%	-41.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-52759
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-4743354
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	12001 E. 33rd Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit O
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Aurora
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80010
CY2023Q1	dei	City Area Code CityAreaCode	855
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	633-3738
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10168220	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4365	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24433	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46483	usd
CY2023Q1	bspk	Prepaid Stock Awards PrepaidStockAwards	58569	usd
CY2022Q4	bspk	Prepaid Stock Awards PrepaidStockAwards	80113	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	26356	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7186	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	13010	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	148783	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	111732	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48162	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9947	usd
CY2023Q1	bspk	License License	10000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	259564	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	275912	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2023Q1	us-gaap	Assets Assets	478509	usd
CY2022Q4	us-gaap	Assets Assets	409591	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	492074	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	295818	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	90000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	692500	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	415500	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1248904	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	865648	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199889	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	216039	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1448793	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1081687	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	bspk	Preferred Stock Design Share PreferredStockDesignShare	1	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2022Q4	bspk	Preferred Stock Design Share PreferredStockDesignShare	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1	shares
CY2023Q1	bspk	Preferred Stock Share State Value PreferredStockShareStateValue	24000	shares
CY2022Q4	bspk	Preferred Stock Share State Value PreferredStockShareStateValue	24000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10168220	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10168220	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9945977	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9945977	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10166	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9944	usd
CY2023Q1	bspk	Common Stock Shares Issued1 CommonStockSharesIssued1	6478	shares
CY2022Q4	bspk	Common Stock Shares Issued1 CommonStockSharesIssued1	6478	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23343968	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23201758	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24324418	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23883798	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-970284	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-672096	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	478509	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	409591	usd
CY2023Q1	us-gaap	Revenues Revenues	89016	usd
CY2022Q1	us-gaap	Revenues Revenues	3061	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	78667	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	847	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	10349	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	2214	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	374515	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	897534	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	61204	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	54355	usd
CY2023Q1	bspk	Consulting Fees ConsultingFees	18000	usd
CY2022Q1	bspk	Consulting Fees ConsultingFees	23000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	453719	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	974889	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-443370	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-972675	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	2750	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	181	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2750	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	181	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440620	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-972494	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-440620	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-972494	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10107108	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6992070	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1989961	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	4792	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	727606	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	197250	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-972494	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1947115	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-672096	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	92432	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-440620	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-970284	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-440620	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-972494	usd
CY2023Q1	bspk	Inventory Reserve InventoryReserve	40393	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1785	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	16348	usd
CY2023Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	21544	usd
CY2022Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	15745	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	92432	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	727606	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	46483	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	64	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	19170	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-996	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53403	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-355	usd
CY2022Q1	bspk	Interest Receivable Wonder Leaf InterestReceivableWonderLeaf	181	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	196256	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	22892	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16150	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14648	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-207068	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-219793	usd
CY2022Q1	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	6443	usd
CY2022Q1	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	20000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7202	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33645	usd
CY2022Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	4792	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	90000	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	277000	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2500	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	197250	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	187000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	199542	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20068	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53896	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24433	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	148227	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4365	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94331	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	50000	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	222223	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2023Q1	us-gaap	Gain On Cash Flow Hedge Ineffectiveness GainOnCashFlowHedgeIneffectiveness	207068	usd
CY2023Q1	bspk	Working Capital Deficit WorkingCapitalDeficit	1100121	usd
CY2023Q1	us-gaap	Accumulated Capitalized Interest Costs AccumulatedCapitalizedInterestCosts	24324418	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. </p>
CY2023Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q1	bspk	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	692500	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13010	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	0	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	13010	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2022	bspk	Total Accounts Receivable TotalAccountsReceivable	0.10	pure
CY2023Q1	bspk	Numberof Customers NumberofCustomers	three
CY2023Q1	bspk	Total Sales In Percentage TotalSalesInPercentage	0.459	pure
CY2022Q1	bspk	Total Sales In Percentage TotalSalesInPercentage	0.10	pure
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior gross prepaid stock compensation and additional paid in capital presented in the 10Q for the period end March 31, 2022 have been reclassified to conform with the financials filed in the December 31, 2022 10K.</p>
CY2022Q1	bspk	Shares Warrants SharesWarrants	562.967	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1022842	shares
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	222223	shares
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2023Q1	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	50000	usd
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	222223	shares
CY2023Q1	us-gaap	Taxes And Licenses TaxesAndLicenses	10000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	40000	usd
CY2022Q3	bspk	Operating Profit Sale Percentage OperatingProfitSalePercentage	0.40	pure
CY2022Q3	bspk	Inventory Earn Out InventoryEarnOut	75000	usd
CY2022Q4	bspk	Inventory Earn Out InventoryEarnOut	90000	usd
CY2022Q4	bspk	Note Payable Related Parties Classified Current NotePayableRelatedPartiesClassifiedCurrent	415500	usd
CY2022Q1	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	10000	usd
CY2022Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.05	pure
CY2022Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2023-01-18
CY2022Q1	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	10000	usd
CY2022Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.05	pure
CY2022Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2023-02-08
CY2022Q4	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	25000	usd
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.05	pure
CY2022Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2023-02-08
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	931	usd
CY2022	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	45931	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49947	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9947	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1785	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48162	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9947	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1785	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	0	usd
CY2023Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	227000	usd
CY2023Q1	us-gaap	Lessee Finance Lease Remaining Lease Term LesseeFinanceLeaseRemainingLeaseTerm	P5Y
CY2023Q1	us-gaap	Lessee Finance Lease Renewal Term1 LesseeFinanceLeaseRenewalTerm1	P5Y
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	6000	usd
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	600000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M8D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	19093	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	20143	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	56700	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	75915	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	79380	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	72765	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	284760	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	23291	usd
CY2023Q1	bspk	Total Present Value Of Lease Liabilities TotalPresentValueOfLeaseLiabilities	264219	usd
CY2023Q1	bspk	Rightofuse Assets Classification RightofuseAssetsClassification	Right of use assets
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	259564	usd
CY2023Q1	bspk	Current Lease Liabilities Classification CurrentLeaseLiabilitiesClassification	Current operating lease liabilities
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64330	usd
CY2023Q1	bspk	Noncurrent Lease Liabilities Classification NoncurrentLeaseLiabilitiesClassification	Long-term operating lease liabilities
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	199889	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	264219	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	222223	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	50000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.225
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	675000	usd
CY2021Q4	bspk	Stock Based Compensation Description StockBasedCompensationDescription	the Company entered into an employment agreement with Michael Feinsod, the Company’s chief executive officer and chairman. Pursuant to the employment agreement, Mr. Feinsod will continue to serve as the Company’s chief executive officer and chairman and will receive a base monthly salary of $10,000. The Company also granted to Mr. Feinsod, pursuant to the Company’s 2021 Equity Incentive Plan, 1,000,000 shares of restricted common stock valued at $1,350,000 ($1.35 per share), which vested one year from the date of grant. During the year ended December 31, 2022 the Company recorded $1,350,000 of prepaid expenses associated with the stock based compensation.
CY2022	bspk	Shares Issued To Investors SharesIssuedToInvestors	1530897	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1530897	shares
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	344450	usd
CY2022	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-30
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	2.25
CY2022Q3	bspk	Shares Of Common Stock SharesOfCommonStock	266667	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	155556	shares
CY2022	us-gaap	Other Expenses OtherExpenses	1104928	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	21544	usd
CY2023Q1	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	58569	usd
CY2022	us-gaap	Restricted Stock Award Forfeitures RestrictedStockAwardForfeitures	80113	usd
	bspk	Shares Issued To Investors SharesIssuedToInvestors	50000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	12500000	shares
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	250000	usd
	us-gaap	Legal Fees LegalFees	10000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P1Y
	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	2.25
CY2023Q1	us-gaap	Fair Value Option Credit Risk Gains Losses On Assets FairValueOptionCreditRiskGainsLossesOnAssets	450000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	30811	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	97797	usd
CY2021Q4	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	22222	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.35
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	30000	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	24900	usd
CY2023Q1	us-gaap	Present Value Of Future Insurance Profits Amortization Expense1 PresentValueOfFutureInsuranceProfitsAmortizationExpense1	420381	usd
CY2022	bspk	Advance Amount AdvanceAmount	415500	usd
CY2023Q1	bspk	Advance Amount AdvanceAmount	277000	usd
CY2023Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	105000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	78936	usd
CY2021Q3	bspk	Principal Amounts PrincipalAmounts	400000	usd
CY2022Q3	bspk	Operating Profit Percentage OperatingProfitPercentage	0.40	pure
CY2022Q3	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	75000	usd
CY2022Q4	us-gaap	Progress Payments Netted Against Inventory For Long Term Contracts Or Programs ProgressPaymentsNettedAgainstInventoryForLongTermContractsOrPrograms	90000	usd
CY2022Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	3	usd
CY2021Q4	bspk	Executive Officer Salary ExecutiveOfficerSalary	8000	usd
CY2021Q4	bspk	Stock Issued During Period Shares Others StockIssuedDuringPeriodSharesOthers	666667	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	0.06
CY2021Q4	bspk	Premium Percentage PremiumPercentage	1.20	pure
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	2777778	shares
CY2023Q1	us-gaap	Securities Loaned SecuritiesLoaned	157000	usd
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Bespoke Extracts, Inc.
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023Q1	bspk	Common Stock Value1 CommonStockValue1		usd
CY2022Q4	bspk	Common Stock Value1 CommonStockValue1		usd
CY2023Q1	us-gaap	Interest Expense InterestExpense		usd
CY2022Q1	us-gaap	Interest Expense InterestExpense		usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10107108	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6992070	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	bspk	Inventory Reserve InventoryReserve		usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q1	bspk	Interest Receivable Wonder Leaf InterestReceivableWonderLeaf		usd
CY2023Q1	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate		usd
CY2023Q1	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders		usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter		usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001409197

Files In Submission

Name	View Source	Status
0001213900-23-057025-index-headers.html	Edgar Link	pending
0001213900-23-057025-index.html	Edgar Link	pending
0001213900-23-057025.txt	Edgar Link	pending
0001213900-23-057025-xbrl.zip	Edgar Link	pending
bspk-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_bespoke.htm	Edgar Link	pending
f10q0323ex32-1_bespoke.htm	Edgar Link	pending
f10q0323_bespoke.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
bspk-20230331_def.xml	Edgar Link	unprocessable
bspk-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_bespoke_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bspk-20230331_cal.xml	Edgar Link	unprocessable
bspk-20230331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BSPK
Bespoke Extracts, Inc. Stock $bspk

2023 Q3 Form 10-Q Financial Statement

#000121390023057025 Filed on July 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSPK Bespoke Extracts, Inc. Stock $bspk

2023 Q3 Form 10-Q Financial Statement

#000121390023057025 Filed on July 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BSPK
Bespoke Extracts, Inc. Stock $bspk